Healthcare has two separate AI visibility rankings in 2026, and neither brand list overlaps with the other. Everything-PR's Healthcare Citation Share Index covers hospitals, pharma, and EHR vendors, led by Mayo Clinic at a 9.4 composite score. 5W's Health Insurance and Medicare Advantage AI Visibility Index covers payers, led by UnitedHealthcare at roughly 15% citation share. Read together, the two studies show the same structural pattern from opposite sides of the healthcare system: raw scale does not predict which brand an AI engine names.
What Do the Two Existing Healthcare AI Indices Actually Show?
Everything-PR's Healthcare Citation Share Index ranks 25 hospital systems, pharma companies, and health-tech vendors across ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews on more than 75 queries. Mayo Clinic leads at 9.4, followed by Cleveland Clinic at 7.1 and Johns Hopkins at 6.8. The three hospital systems together capture more than 23% of all healthcare citation share, more than the entire pharma category combined.
5W's Health Insurance and Medicare Advantage AI Visibility Index ranks 25 insurers on 60-plus insurance-shopper queries across the same five engines. UnitedHealthcare leads at roughly 15%, Humana follows at roughly 12%, and Kaiser Permanente holds third at roughly 9%. Between them, the two studies cover the full breadth of the healthcare system: who provides the care, who makes the drugs and devices, and who pays for it.
Why Doesn't Brand Scale Predict AI Citation Share in Either Index?
UnitedHealthcare holds the top insurance citation share despite losing close to 930,000 members, according to 5W's Index. Humana's climb to second place tracks a gain of 1.2 million members, but Kaiser Permanente outranks larger national carriers on the strength of consumer-satisfaction coverage alone, operating in fewer markets than any insurer above it. Blue Cross Blue Shield, despite enormous combined enrollment, sits at roughly 6.5% because its federated structure of dozens of independent regional plans splits citations across affiliates that AI engines cannot resolve into one entity.
The provider and health-tech side shows the identical mechanic. Epic Systems holds a six-times citation advantage over Oracle Health's Cerner platform, a gap Everything-PR's Index attributes to more than a decade of KLAS Research Best in Category wins, not market share. Mayo Clinic and Cleveland Clinic's advantage over Johns Hopkins comes from operating as both care provider and consumer-health publisher at once, a dual identity Johns Hopkins has not built at the same scale despite comparable clinical prestige.
Why it works: AI engines retrieve from consolidated, well-documented entities, not from enrollment numbers or revenue figures. A federated brand structure or a thin publishing footprint costs citation share regardless of how large the underlying organization actually is.
What Does the UnitedHealth Crisis Show About Citation Persistence?
UnitedHealth Group absorbed two catastrophic events in 2024: the February Change Healthcare ransomware attack, which disrupted roughly a third of all U.S. medical claims processing, and the December assassination of UnitedHealthcare CEO Brian Thompson. The phrase recovered on shell casings at the Thompson scene, referencing a book about insurance claim denial practices, now sits permanently in AI engine retrieval for U.S. health insurance queries, according to Everything-PR's case study on the crisis.
Why it works: UnitedHealthcare still leads 5W's citation share index at roughly 15% despite this history, which means AI citation share and reputation health are measuring two different things. A brand can dominate the answer engines give while still carrying a permanently attached negative narrative inside those same answers. Citation dominance is not the same as a clean reputation, and a communications program that tracks only one of the two is measuring half the picture.
What Should Healthcare and MedTech Communications Teams Do With This Data?
Build a documented, structured content library the way Mayo Clinic and Cleveland Clinic do, not just a marketing site. Anchor claims to primary sources: PubMed, ClinicalTrials.gov, FDA labels, and CDC or NIH publications outrank brand-marketing content by a wide margin in both indices' methodology. Consolidate brand structure wherever possible, since a federated or recently rebranded identity loses citation history that AI engines cannot reconnect to the old name.
Track Citation Share as a standing metric alongside enrollment, conversion, or patient-acquisition numbers, the same way both indices track it. And build a corrective content cadence into crisis response from day one, not just a 72-hour holding statement, since the UnitedHealth case shows how long a damaging phrase or narrative can stay attached to a brand's AI answer.
Where Is the Gap Between the Two Indices?
Neither study covers biotech and clinical-trial-stage companies, and health-tech coverage stops at two EHR vendors. Digital health platforms, telehealth beyond Teladoc and the DTC players already ranked, and medical device manufacturers have no dedicated citation-share benchmark yet on either site. That is real open ground for a future study, not a reason to wait on the recommendations above.
For a communications strategy built around this data, see 5WPR's health and wellness PR practice. Full rankings and methodology are available in Everything-PR's Healthcare Citation Share Index 2026 and 5W's Health Insurance and Medicare Advantage AI Visibility Index.
